Business Development Deal Architecture
  • Search OnBioBD:

  • OnBioBD OldSkool NEWS:

    - OnBioVC 4Q11 Trend Analysis, now available
    - OnBioVC 1Q12 White Paper, now available
    - OnBioVC 1Q12 Trend Analysis, coming soon

  • FDA Registered Contract Manufacturer

Sage Therapeutics (Watertown, MA) a development-stage pharmaceutical company focused on modulators of neuronal activity for schizophrenia, depression, pain and traumatic brain injury, closed a $35M Series A financing. Participants include Third Rock Ventures.

CeNeRx (Cary, NC) a clinical-stage biopharmaceutical company focused on diseases of the central nervous system, depression and anxiety, closed a $4.6M Series D financing. Participants include Aisling Capital, L Capital Partners, Perseus Soros Biopharmaceutical Fund, Omega Funds and Pappas Ventures.

MSI Methylation Sciences (Canada) a preclinical-stage pharmaceutical company focused on depression, closed a $18.2M Series A financing. Participants include Inventages, GrowthWorks and BC Advantage Funds.

Naurex (Evanston, IL) a clinical-stage pharmaceutical company focused on depression and other CNS-related disorders, closed a $18M Series A financing. Participants include Adams Street Partners, Latterell Venture Partners, Druid BioVentures, Genesys Capital, PathoCapital, Lundbeck, Takeda Ventures and Shire.

Euthymics Bioscience (Cambridge, MA) a clinical-stage small molecule company focused on CNS disorders and depression, closed a $24M Series A financing. Participants include Novartis Venture Fund, Venture Investors, H&Q Capital Management and GBS Venture Partners.

Marinus Pharmaceuticals (Branford, CT) a clinical-stage company focused on reformulation and development of therapeutics for the treatment of CNS, psychiatric and pain disorders, closed a $20M Series B financing. Participants include Canaan Partners, Domain Associates, Sofinnova Ventures and Foundation Medical Partners.

CeNeRx BioPharma (Cary, NC) developer of CNS therapeutics for depression, anxiety and epilepsy, closed a $15M Series B financing. Participants include Aisling Capital, L Capital Partners and Pappas Ventures.

  

to top of page...